Skip to main content

Advertisement

Table 3 Lifetime costs and life expectancy results for base case and sensitivity analyses

From: Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya

Scenario Strategy Lifetime costs Life expectancy (years from screening)
Societal perspective Clinic perspective
Base case Preventative cryotherapy $99 $19 17.3
VIA $196 $94 17.1
PAP $219 $124 17.1
HPV $223 $113 17.1
VIA + HPV $258 $150 17.0
HPV + PAP $261 $155 17.0
VIA + PAP $263 $158 17.0
Sensitivity analyses
 Low CD4 (CD4 ≤ 200 cells/mL) Preventative cryotherapy $122 $22 15.3
VIA $208 $87 15.2
HPV $262 $125 15.2
PAP $281 $152 15.1
VIA + HPV $339 $194 15.0
HPV + PAP $342 $199 15.0
VIA + PAP $348 $205 15.0
 High CD4 (CD4 > 500 cells/mL) Preventative cryotherapy $49 $13 20.0
VIA $99 $51 19.9
HPV $102 $56 19.9
VIA + HPV $105 $69 19.9
PAP $115 $71 19.9
HPV + PAP $119 $80 19.9
VIA + PAP $105 $72 19.8
  1. Pap Papanicolaou smear, HPV DNA testing for Human Papilloma Virus, VIA visual inspection of the cervix with acetic acid